TAGRAXOFUSP

TAGRAXOFUSP was reported 538 times

TAGRAXOFUSP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANGIOGENESIS BIOMARKER DECREASED 4 0.6667
1 CAPILLARY PERMEABILITY 1 0.2000
2 RED BLOOD CELL ACANTHOCYTES PRESENT 3 0.1500
3 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 10 0.1235
4 TROPONIN I 1 0.0667
5 CAPILLARY LEAK SYNDROME 130 0.0628
6 ROULEAUX FORMATION 3 0.0517
7 CSF LACTATE INCREASED 1 0.0333
8 CAPILLARY PERMEABILITY INCREASED 2 0.0308
9 ORBITAL SWELLING 1 0.0172
10 SKIN LESION INFLAMMATION 2 0.0152
11 THROMBOEMBOLECTOMY 1 0.0104
12 FASCIOTOMY 1 0.0089
13 MICROEMBOLISM 1 0.0088
14 BONE MARROW NECROSIS 2 0.0085
15 BLOOD LACTIC ACID 1 0.0078
16 OCULAR RETROBULBAR HAEMORRHAGE 1 0.0072
17 LEUKAEMIA CUTIS 1 0.0065
18 BLUE TOE SYNDROME 2 0.0051
19 GRAM STAIN POSITIVE 1 0.0049
20 LEUKAEMIA RECURRENT 8 0.0047
21 BLOOD STEM CELL TRANSPLANT FAILURE 1 0.0047
22 ENDOTHELIAL DYSFUNCTION 1 0.0043
23 NEOPLASM RECURRENCE 14 0.0041
24 PSEUDOMONAL SEPSIS 7 0.0040
25 COOMBS TEST POSITIVE 1 0.0037
26 BLOOD ALBUMIN DECREASED 29 0.0037
27 DEVICE RELATED SEPSIS 7 0.0035
28 HYPOALBUMINAEMIA 25 0.0032
29 TUMOUR LYSIS SYNDROME 27 0.0031
30 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
31 POVERTY OF SPEECH 1 0.0026
32 MYOCARDIAL OEDEMA 1 0.0025
33 INFUSION 1 0.0024
34 CHLOROMA 1 0.0024
35 CORONA VIRUS INFECTION 1 0.0023
36 HYPERFERRITINAEMIA 1 0.0023
37 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
38 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
39 CRANIAL NERVE PARALYSIS 1 0.0021
40 RENAL HAEMATOMA 1 0.0019
41 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
42 PLEOCYTOSIS 1 0.0017
43 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
44 ENTEROCOCCUS TEST POSITIVE 1 0.0015
45 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
46 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
47 PLEURAL THICKENING 1 0.0015
48 STASIS DERMATITIS 1 0.0015
49 FEELING OF RELAXATION 1 0.0015
50 HYPERTRANSAMINASAEMIA 10 0.0014
51 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
52 CREATINE KINASE INCREASED 1 0.0013
53 VASCULAR ACCESS COMPLICATION 1 0.0012
54 PSEUDOMONAS TEST POSITIVE 1 0.0012
55 CSF PROTEIN INCREASED 1 0.0012
56 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
57 TONGUE COATED 2 0.0012
58 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
59 THERAPEUTIC RESPONSE INCREASED 1 0.0011
60 HYPERVOLAEMIA 5 0.0010
61 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
62 TRANSAMINASES INCREASED 22 0.0010
63 BLAST CELL COUNT INCREASED 1 0.0010
64 LIVER FUNCTION TEST INCREASED 19 0.0009
65 BLOOD FIBRINOGEN DECREASED 1 0.0009
66 MONOCYTE COUNT INCREASED 3 0.0008
67 VENOOCCLUSIVE DISEASE 2 0.0008
68 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
69 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
70 ALVEOLITIS 1 0.0007
71 ATYPICAL PNEUMONIA 2 0.0007
72 PALLIATIVE CARE 1 0.0007
73 SINUS ARREST 1 0.0006
74 HEPATOTOXICITY 14 0.0006
75 RESUSCITATION 1 0.0006
76 PNEUMONIA KLEBSIELLA 1 0.0005
77 AMYLASE INCREASED 2 0.0005
78 BONE MARROW TRANSPLANT 1 0.0005
79 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
80 ABDOMINAL WALL HAEMATOMA 1 0.0005
81 BICYTOPENIA 1 0.0005
82 VASCULAR STENT THROMBOSIS 1 0.0005
83 FACIAL PARALYSIS 4 0.0005
84 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
85 HYPERPHOSPHATAEMIA 1 0.0005
86 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
87 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
88 CLOSTRIDIUM TEST POSITIVE 1 0.0005
89 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
90 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
91 HYPERNATRAEMIA 2 0.0004
92 STEM CELL TRANSPLANT 1 0.0004
93 FLUID INTAKE REDUCED 2 0.0004
94 CATHETER SITE PAIN 1 0.0004
95 BLOOD LACTIC ACID INCREASED 2 0.0004
96 HYPOXIA 13 0.0004
97 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
98 ENDOTRACHEAL INTUBATION 1 0.0004
99 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
100 ANURIA 3 0.0003
101 ENTEROCOLITIS 2 0.0003
102 DYSPNOEA AT REST 1 0.0003
103 SKIN LESION 9 0.0003
104 DISEASE PROGRESSION 38 0.0003
105 THROMBOCYTOPENIA 35 0.0003
106 LIVER ABSCESS 1 0.0003
107 SUDDEN CARDIAC DEATH 1 0.0003
108 AORTIC STENOSIS 1 0.0003
109 FACIAL PARESIS 1 0.0003
110 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
111 THROMBOCYTOSIS 1 0.0003
112 CARDIAC DYSFUNCTION 1 0.0003
113 PROTEIN TOTAL DECREASED 1 0.0003
114 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
115 GASTRIC HAEMORRHAGE 3 0.0003
116 EPIGASTRIC DISCOMFORT 1 0.0003
117 HEPATIC ENZYME INCREASED 17 0.0002
118 CYTOPENIA 3 0.0002
119 NEOPLASM PROGRESSION 8 0.0002
120 SEPTIC SHOCK 10 0.0002
121 LUNG INFILTRATION 2 0.0002
122 ABDOMINAL ABSCESS 1 0.0002
123 BLOOD BILIRUBIN INCREASED 6 0.0002
124 VASCULAR DEVICE INFECTION 1 0.0002
125 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
126 LOCALISED OEDEMA 1 0.0002
127 RENAL FUNCTION TEST ABNORMAL 1 0.0002
128 SEPSIS 23 0.0002
129 THERAPY CHANGE 2 0.0002
130 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
131 DRUG TOLERANCE 1 0.0002
132 TOE AMPUTATION 1 0.0002
133 PERIORBITAL OEDEMA 1 0.0002
134 FEBRILE NEUTROPENIA 12 0.0002
135 COAGULOPATHY 3 0.0002
136 NECROSIS 1 0.0002
137 HEART RATE ABNORMAL 1 0.0002
138 ACUTE PULMONARY OEDEMA 1 0.0002
139 SKIN TOXICITY 1 0.0002
140 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
141 METABOLIC DISORDER 1 0.0002
142 NEUTROPHIL COUNT DECREASED 7 0.0002
143 HYPERTRIGLYCERIDAEMIA 1 0.0002
144 ACUTE MYOCARDIAL INFARCTION 5 0.0002
145 BACTERAEMIA 2 0.0002
146 CATARACT OPERATION 1 0.0002
147 GANGRENE 1 0.0002
148 LEUKOCYTOSIS 3 0.0002
149 HEPATIC FUNCTION ABNORMAL 6 0.0002
150 ACUTE KIDNEY INJURY 24 0.0002
151 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
152 ACUTE RESPIRATORY FAILURE 3 0.0002
153 PULMONARY CONGESTION 2 0.0002
154 CARDIAC FAILURE ACUTE 1 0.0001
155 CYTOKINE RELEASE SYNDROME 3 0.0001
156 OEDEMA 8 0.0001
157 DISEASE RECURRENCE 7 0.0001
158 ENCEPHALITIS 1 0.0001
159 MENTAL STATUS CHANGES 4 0.0001
160 LYMPHADENOPATHY 5 0.0001
161 HAND FRACTURE 1 0.0001
162 PLATELET COUNT DECREASED 15 0.0001
163 BRONCHOSPASM 2 0.0001
164 GRAFT VERSUS HOST DISEASE 1 0.0001
165 HYPERGLYCAEMIA 5 0.0001
166 PYREXIA 47 0.0001
167 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
168 ATRIAL FIBRILLATION 13 0.0001
169 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
170 AORTIC ANEURYSM 1 0.0001
171 HYPERTHERMIA 1 0.0001
172 LIPASE INCREASED 1 0.0001
173 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
174 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
175 WEIGHT INCREASED 28 0.0001
176 BLOOD PRESSURE FLUCTUATION 3 0.0001
177 DECUBITUS ULCER 1 0.0001
178 HICCUPS 1 0.0001
179 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
180 NEUROTOXICITY 2 0.0001
181 HEAVY MENSTRUAL BLEEDING 1 0.0001
182 HYPOTENSION 22 0.0001
183 PANCYTOPENIA 6 0.0001
184 BLOOD CREATININE INCREASED 7 0.0001
185 DIARRHOEA HAEMORRHAGIC 1 0.0001
186 OXYGEN SATURATION DECREASED 6 0.0001
187 BLOOD SODIUM DECREASED 2 0.0001
188 LEUKAEMIA 1 0.0001
189 LIVER FUNCTION TEST ABNORMAL 3 0.0001
190 THROMBOTIC MICROANGIOPATHY 1 0.0001
191 HOSPICE CARE 1 0.0001
192 HYPOTONIA 1 0.0001
193 HYPOTHERMIA 1 0.0001
194 SUBARACHNOID HAEMORRHAGE 1 0.0001
195 SKELETAL INJURY 1 0.0001
196 HYPERBILIRUBINAEMIA 1 0.0001
197 TRANSFUSION 1 0.0001
198 FULL BLOOD COUNT ABNORMAL 1 0.0001
199 SUDDEN DEATH 1 0.0001
200 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
201 RETCHING 2 0.0001
202 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
203 RENAL FAILURE 12 0.0001
204 TACHYCARDIA 8 0.0001
205 HYPERTENSIVE CRISIS 1 0.0001
206 MALNUTRITION 1 0.0001
207 MYOCARDITIS 1 0.0001
208 SHOCK 2 0.0001
209 PERICARDIAL EFFUSION 2 0.0001
210 DELIRIUM 3 0.0001
211 COVID-19 PNEUMONIA 1 0.0001
212 CHOLECYSTITIS 1 0.0001
213 POLYNEUROPATHY 1 0.0001
214 C-REACTIVE PROTEIN INCREASED 3 0.0001
215 RESPIRATORY FAILURE 6 0.0001
216 PLEURAL EFFUSION 5 0.0001
217 ENCEPHALOPATHY 2 0.0001
218 CONFUSIONAL STATE 13 0.0001
219 HEPATIC CYTOLYSIS 1 0.0001
220 HYPOPHAGIA 2 0.0001
221 INFLAMMATION 4 0.0001
222 CHILLS 9 0.0001
223 OEDEMA PERIPHERAL 9 0.0001
224 TACHYPNOEA 1 0.0001
225 CARDIAC ARREST 6 0.0001
226 BLINDNESS UNILATERAL 1 0.0001
227 HEPATOCELLULAR INJURY 1 0.0001
228 DIALYSIS 1 0.0001
229 CARDIOGENIC SHOCK 1 0.0001
230 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
231 LABORATORY TEST ABNORMAL 2 0.0001
232 LIVER DISORDER 3 0.0001
233 PULMONARY OEDEMA 3 0.0001
234 HEPATIC FAILURE 2 0.0001
235 BLOOD COUNT ABNORMAL 1 0.0001
236 DEVICE FAILURE 1 0.0001
237 INSURANCE ISSUE 1 0.0001
238 DEVICE RELATED INFECTION 1 0.0001
239 LUNG INFECTION 1 0.0001
240 ACUTE MYELOID LEUKAEMIA 1 0.0001
241 THERAPY PARTIAL RESPONDER 1 0.0001
242 CYANOSIS 1 0.0001
243 INTERSTITIAL LUNG DISEASE 3 0.0001
244 VENTRICULAR TACHYCARDIA 1 0.0001
245 INFUSION RELATED REACTION 4 0.0001
246 BLOOD PRESSURE DECREASED 4 0.0001
247 CYTOMEGALOVIRUS INFECTION 1 0.0001
248 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
249 FACE OEDEMA 1 0.0001
250 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
251 MUSCULOSKELETAL DISCOMFORT 1 0.0001
252 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
253 THIRST 1 0.0001
254 CEREBRAL HAEMORRHAGE 2 0.0001
255 ANAPHYLACTIC REACTION 3 0.0001
256 AGRANULOCYTOSIS 1 0.0001
257 PNEUMONIA 17 0.0001
258 PULMONARY FIBROSIS 1 0.0001
259 LOWER LIMB FRACTURE 1 0.0001
260 BACK PAIN 12 0.0001
261 NEUTROPENIA 7 0.0001
262 HAEMATOCRIT DECREASED 1 0.0001
263 CARDIAC FAILURE 4 0.0000
264 THERAPEUTIC RESPONSE DECREASED 3 0.0000
265 OFF LABEL USE 43 0.0000
266 BODY TEMPERATURE INCREASED 1 0.0000
267 RHABDOMYOLYSIS 2 0.0000
268 DEATH 41 0.0000
269 HALLUCINATION, VISUAL 1 0.0000
270 POOR QUALITY SLEEP 1 0.0000
271 DEEP VEIN THROMBOSIS 3 0.0000
272 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
273 SNEEZING 1 0.0000
274 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
275 THERAPY INTERRUPTED 3 0.0000
276 MENTAL IMPAIRMENT 1 0.0000
277 LIVER INJURY 1 0.0000
278 PNEUMONIA ASPIRATION 1 0.0000
279 LEUKOPENIA 2 0.0000
280 SYNCOPE 4 0.0000
281 FLUID RETENTION 2 0.0000
282 DRUG RESISTANCE 1 0.0000
283 ANAPHYLACTIC SHOCK 1 0.0000
284 UNRESPONSIVE TO STIMULI 1 0.0000
285 MUCOSAL INFLAMMATION 1 0.0000
286 PANCREATITIS 2 0.0000
287 PNEUMONITIS 1 0.0000
288 RESPIRATORY DISTRESS 1 0.0000
289 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
290 HAEMOPTYSIS 1 0.0000
291 RENAL IMPAIRMENT 3 0.0000
292 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
293 SEIZURE 4 0.0000
294 RENAL INJURY 1 0.0000
295 JOINT SWELLING 4 0.0000
296 LACRIMATION INCREASED 1 0.0000
297 STOMATITIS 2 0.0000
298 ADVERSE EVENT 3 0.0000
299 PERIPHERAL SWELLING 5 0.0000
300 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
301 NERVOUS SYSTEM DISORDER 1 0.0000
302 DRUG-INDUCED LIVER INJURY 1 0.0000
303 PULMONARY EMBOLISM 3 0.0000
304 NEUROPATHY PERIPHERAL 3 0.0000
305 ANAEMIA 6 0.0000
306 CYSTITIS 1 0.0000
307 METABOLIC ACIDOSIS 1 0.0000
308 LACTIC ACIDOSIS 1 0.0000
309 FUNGAL INFECTION 1 0.0000
310 GAIT INABILITY 1 0.0000
311 ASTHENIA 11 0.0000
312 HAEMOGLOBIN DECREASED 3 0.0000
313 HAEMATURIA 1 0.0000
314 HEART RATE DECREASED 1 0.0000
315 HYPERTENSION 6 0.0000
316 DYSPNOEA 16 0.0000
317 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
318 MYELOSUPPRESSION 1 0.0000
319 PANIC ATTACK 1 0.0000
320 DYSPNOEA EXERTIONAL 1 0.0000
321 UNEVALUABLE EVENT 2 0.0000
322 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
323 DISORIENTATION 1 0.0000
324 LUNG NEOPLASM MALIGNANT 1 0.0000
325 HYPOACUSIS 1 0.0000
326 BALANCE DISORDER 2 0.0000
327 ADVERSE DRUG REACTION 2 0.0000
328 THERAPY NON-RESPONDER 1 0.0000
329 SKIN DISCOLOURATION 1 0.0000
330 HYPOKALAEMIA 1 0.0000
331 RENAL DISORDER 1 0.0000
332 COGNITIVE DISORDER 1 0.0000
333 SWELLING 2 0.0000
334 DRUG INEFFECTIVE 28 0.0000
335 DYSPHAGIA 2 0.0000
336 RASH ERYTHEMATOUS 1 0.0000
337 CONTUSION 2 0.0000
338 FATIGUE 16 0.0000
339 MALAISE 9 0.0000
340 LUNG DISORDER 1 0.0000
341 THERAPY CESSATION 1 0.0000
342 DEPRESSED MOOD 1 0.0000
343 HAEMATOCHEZIA 1 0.0000
344 ABDOMINAL DISCOMFORT 3 0.0000
345 HYPONATRAEMIA 1 0.0000
346 EYE PAIN 1 0.0000
347 HERPES ZOSTER 1 0.0000
348 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
349 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
350 ILL-DEFINED DISORDER 1 0.0000
351 DISCOMFORT 1 0.0000
352 FEELING HOT 1 0.0000
353 CHEST PAIN 3 0.0000
354 RHINORRHOEA 1 0.0000
355 SWELLING FACE 1 0.0000
356 NAUSEA 12 0.0000
357 DEHYDRATION 2 0.0000
358 NEOPLASM MALIGNANT 1 0.0000
359 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
360 INFECTION 2 0.0000
361 RASH 6 0.0000
362 CONSTIPATION 3 0.0000
363 UNDERDOSE 1 0.0000
364 AGITATION 1 0.0000
365 BRONCHITIS 1 0.0000
366 EPISTAXIS 1 0.0000
367 BLOOD PRESSURE INCREASED 2 0.0000
368 HOSPITALISATION 2 0.0000
369 DECREASED APPETITE 3 0.0000
370 ABDOMINAL PAIN 3 0.0000
371 TREMOR 2 0.0000
372 FALL 4 0.0000
373 TOXICITY TO VARIOUS AGENTS 2 0.0000
374 URINARY TRACT INFECTION 2 0.0000
375 PRODUCT STORAGE ERROR 1 0.0000
376 PAIN IN EXTREMITY 3 0.0000
377 DYSPEPSIA 1 0.0000
378 HEART RATE INCREASED 1 0.0000
379 DIZZINESS 5 0.0000
380 SOMNOLENCE 2 0.0000
381 CONDITION AGGRAVATED 3 0.0000
382 SINUSITIS 1 0.0000
383 ABDOMINAL PAIN UPPER 2 0.0000
384 ABDOMINAL DISTENSION 1 0.0000
385 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
386 MUSCULAR WEAKNESS 1 0.0000
387 HEADACHE 5 0.0000
388 WEIGHT DECREASED 2 0.0000
389 COUGH 2 0.0000
390 PRODUCT DOSE OMISSION ISSUE 2 0.0000
391 VOMITING 3 0.0000
392 MYOCARDIAL INFARCTION 1 0.0000
393 MUSCLE SPASMS 1 0.0000
394 NASOPHARYNGITIS 1 0.0000
395 HYPERSENSITIVITY 1 0.0000
396 PRODUCT USE ISSUE 1 0.0000
397 PAIN 3 0.0000
398 DIARRHOEA 3 0.0000
399 DEPRESSION 1 0.0000
400 INCORRECT DOSE ADMINISTERED 1 0.0000
401 INSOMNIA 1 0.0000
402 ANXIETY 1 0.0000
403 ARTHRALGIA 1 0.0000